Ribobay Pharma Offers oligo CRDMO Services with Cytiva FlexFactory Platform
Ribobay Pharma has announced that it will provide cGMP-level oligonucleotide (oligo) CRDMO services to the world using Cytiva's first FlexFactory platform for oligo manufacturing.
Oligonucleotide | 13/05/2024 | By Aishwarya
WuXi STA opens new manufacturing facility
WuXi STA opens new large-scale Oligonucleotide and Peptide manufacturing facility
Oligonucleotide | 08/07/2022 | By Sudeep Soparkar | 341
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy